IRIS
LUNGHI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.007
AS - Asia 7.871
EU - Europa 5.376
SA - Sud America 853
AF - Africa 336
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 8
Totale 22.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.762
SG - Singapore 2.906
CN - Cina 2.391
VN - Vietnam 1.079
IE - Irlanda 886
FI - Finlandia 885
IT - Italia 808
DE - Germania 738
SE - Svezia 707
BR - Brasile 681
HK - Hong Kong 535
UA - Ucraina 477
TR - Turchia 329
NL - Olanda 244
FR - Francia 225
ZA - Sudafrica 213
CA - Canada 166
IN - India 156
GB - Regno Unito 142
BD - Bangladesh 111
RU - Federazione Russa 62
JP - Giappone 57
AR - Argentina 56
CI - Costa d'Avorio 45
IQ - Iraq 43
MX - Messico 35
AT - Austria 33
KR - Corea 30
PL - Polonia 30
EC - Ecuador 28
ES - Italia 28
PH - Filippine 27
ID - Indonesia 26
PK - Pakistan 25
BE - Belgio 21
RO - Romania 20
VE - Venezuela 20
CO - Colombia 18
LT - Lituania 17
MA - Marocco 17
UZ - Uzbekistan 17
EU - Europa 16
IR - Iran 16
SA - Arabia Saudita 16
TH - Thailandia 16
CL - Cile 15
DZ - Algeria 15
PY - Paraguay 14
CZ - Repubblica Ceca 13
EG - Egitto 13
JO - Giordania 13
TW - Taiwan 10
JM - Giamaica 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
KE - Kenya 7
NP - Nepal 7
TN - Tunisia 7
AZ - Azerbaigian 6
CH - Svizzera 6
CR - Costa Rica 6
MY - Malesia 6
ET - Etiopia 5
GE - Georgia 5
IL - Israele 5
PE - Perù 5
AU - Australia 4
HN - Honduras 4
HR - Croazia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
DK - Danimarca 2
GT - Guatemala 2
KH - Cambogia 2
LK - Sri Lanka 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 22.446
Salva come PNG Salva come JPEG
Città #
Singapore 1.305
Dublin 887
San Jose 886
Jacksonville 727
Ashburn 678
Chandler 667
Beijing 587
Hong Kong 516
Santa Clara 399
Dearborn 394
Ho Chi Minh City 330
Dallas 309
Boardman 285
Nanjing 279
Izmir 275
San Mateo 239
Hanoi 231
Ann Arbor 217
Johannesburg 202
Princeton 202
Lauterbourg 169
Munich 163
Parma 150
Wilmington 150
Los Angeles 142
Helsinki 134
Pittsburgh 123
Toronto 113
Shenyang 112
New York 102
Hefei 100
Shanghai 87
Jinan 85
Kunming 85
Nanchang 83
Hebei 74
São Paulo 60
Buffalo 55
Changsha 55
Haiphong 54
Bologna 53
Tianjin 53
Jiaxing 50
Düsseldorf 49
Tokyo 47
Grafing 46
Abidjan 45
Milan 45
Seattle 45
Woodbridge 45
Guangzhou 40
Da Nang 39
Council Bluffs 38
Columbus 35
Moscow 35
Rio de Janeiro 33
Zhengzhou 32
Des Moines 31
Pune 30
Houston 29
Kocaeli 29
Turku 29
Norwalk 28
Warsaw 28
Atlanta 27
Rome 26
Hangzhou 25
London 25
Montreal 25
Nuremberg 22
Baghdad 21
Brussels 21
Chennai 21
Fremont 21
Leawood 21
Bremen 20
The Dalles 20
Brooklyn 19
Hải Dương 19
Augusta 18
Frankfurt am Main 18
Lanzhou 18
Ningbo 18
Taizhou 18
Boston 17
Denver 17
Haikou 17
Orem 17
Phoenix 17
Stockholm 17
Amsterdam 16
Bengaluru 16
Falls Church 16
San Francisco 16
Seoul 16
Belo Horizonte 15
Chengdu 15
Poplar 15
Tashkent 15
Can Tho 14
Totale 13.324
Salva come PNG Salva come JPEG
Nome #
2,6-Diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activity 321
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 311
Endocanalicular transendothelial crossing (ETC): A novel intravasation mode used by HEK-EBNA293-VEGF-D cells during the metastatic process in a xenograft model 272
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 261
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 255
The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways 228
Acenaphthenequinone Thiosemicarbazone and Its Transition Metal Complexes: Synthesis, Structure, and Biological Activity 222
A translational perspective of the malignant hematopoietic proteoglycome 189
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 187
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 183
Attività biologica del tiosemicarbazone del piridossale e dei suoi complessi di rame 180
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 175
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 173
Alpha and Gamma interferons do not modulate the levels of JNK/SAPK activation in Ph+ leukemic cell lines 172
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 172
Air purification and indoor biologic pollutants 170
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 170
: Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 169
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 168
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure and biological activity 166
L'attività della wortmannin inibitore della fosfatidilinositolo-3 chinasi su cellule di leucemia mieloide cronica in fase cronica 165
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 155
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 154
Acenapthenequinone thiosemicarbazone and its transition metal complexes. Synthesis, structure and biological activity 152
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 150
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 147
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 147
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 145
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 143
Analisi dei meccanismi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 142
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 141
An abatement of the concentration of mycophytes, dust mites and pollens grains in the indoor environment using an air purifier 141
2,6-Diacetylpyridine Bis(Thiosemicarbazones) Zinc Complexes: Synthesis, Structure, and Biological Activity 139
p73 and p53 pathway in human breast cancers. 139
Fosforilazione in tirosina delle proteine adattatrici SHC ed attivazione di ERK-JNK/SAPK kinasi in leucemia acuta mieloblastica 138
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 136
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 135
An abatement of the concentration of mycophytes, dust mites and pollen grains in the indoor environment using an air purifier 133
Transition-Metal Complexes of Isatin-beta-Thiosemicarbazone. X-Ray Crystal Structure of Two Nickel Complexes 132
Emerging MEK inhibitors 131
Tyrosine-phosphorylation of SHC adaptor proteins and activation of ERK-JNK/SAPK MAP kinases in acute myelogenous leukemia 130
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 129
L'inibizione della proliferazione indotta dal tiosemicarbazone della 2-piridina carbossialdeide e dai relativi complessi di stagno in linee cellulari umane e in cellule derivate da pazienti leucemici è associata ad apotosi 129
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 128
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 125
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 125
Emerging Raf inhibitors 124
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 121
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 121
The ontogenesis of BCL2 oncogen protein in human hemopoietic development 121
Arsenic trioxide in hematological malignancies: The new discovery of an ancient drug 121
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 120
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 120
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 118
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 118
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 117
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 116
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 116
High levels of ERK constitutive activity in acute myelogenous leukemia 116
Selective inhibition of MEK1 kinase down-modulates ERK activity and proliferation of acute myeloid leukemia blasts 115
Acetylation of core histone tails in cord blood hematopoietic progenitors 115
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 112
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 111
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 110
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 110
Le IgG normali e quelle di soggetti con lupus eritematoso sistemico esercitano un effetto pro-infiammatorio precoce su cellule tubulari umane 109
Tyrosine phosphorylation of SHC adaptor proteins in chronic myelogenous leukemia 109
High levels of p52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 108
An abatment of the concentration of mycophytes and pollen grains in the indoor environment using an air purifier 108
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting 108
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 107
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 107
Resistance of multiple myeloma cells to trail is overcome by blockade of aurora kinases 107
Attività biologica dei tiosemicarbazoni dell'acido alfa-chetoglutarico e della 2,6 diacetilpiridina 106
Riduzione della concentrazione di micofiti, pollini e allergeni della polvere in ambienti confinati 103
Riduzione di allergeni indoor con purificatore d’aria 102
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 102
Selective inhibition of MEK1 kinase downmodulates ERK activity and proliferation of acute myeloid leukemia blasts 102
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 102
Synthesis, characterization, X-ray strucrure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 102
Espressione dell'oncogene BCL2 in cellule emopoietiche fetali umane 102
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 101
Ontogenesi dell'oncogene BCL2 in tessuti emopoietici fetali 101
Selective inhibition of MEK! Kinase downmodulates ERK activity and prolifaretion of acute myeloid leukemia blasts 101
Ontogenesis of signalling proteins:SHC, ERK, JNK expression and phosphorylation during human heart developpement 101
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 100
Constitutive expression and tyrosine phosphorylation of SHC proteins in chronic myelogenous leukemia 100
The reduction of the concentration of dust mites, mycophites and pollen grains in the indoor environment by means of an air purifier 100
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 100
Riduzione della carica batterica aerodispersa mediante utilizzo di un purificatore d'aria in ambienti indoor 100
High levels of ERK constitutive activity in acute myelogenous leukemia 99
Betulaceae, Corylaceae, Cupressaceae, Fagaceae and Salicaceae around Parma (Northern Italy): pollen calendars from 1995 to 1997 99
Studio della trasduzione del segnale di attivazione cellulare attraverso l'espressione e la fosforilazione di SHC ed ERC chinasi 99
The ontogenesis of BCL2 oncogene protein in human hemopoietic development 99
Chimica, struttura ed attività biologica di sistemi metallo-legante solforato 99
Blockade of Aurora kinases activity enhances APO2L/TRAIL sensitivity in multiple myeloma 98
Constitutive expression and tyrosine phosphorylation of SHC proteins in chronic myelogenous leukemia 98
Analisi dei meccansimi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 98
Analisi della chinasi ERK in leucemia acuta mieloblastica e malattie linfoproliferative croniche 97
Hypoxia and Hypoxia Inducible Factor (HIF)-1α in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment. 97
Totale 13.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022978 18 13 8 26 22 54 110 171 52 122 108 274
2022/20232.957 397 257 179 181 245 308 17 185 1.088 12 77 11
2023/20241.071 77 94 32 30 107 225 84 51 26 71 115 159
2024/20253.824 97 248 256 205 404 307 131 134 597 358 305 782
2025/20267.760 745 727 901 631 1.038 432 973 263 1.117 563 284 86
Totale 22.556